Physicochemical Properties
| Molecular Formula | C24H19F4N5O2 |
| Molecular Weight | 485.4336 |
| Exact Mass | 485.147 |
| CAS # | 2442597-56-8 |
| PubChem CID | 145925694 |
| Appearance | White to yellow solid powder |
| Density | 1.37±0.1 g/cm3(Predicted) |
| Boiling Point | 553.3±50.0 °C(Predicted) |
| LogP | 4.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 35 |
| Complexity | 699 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | IZKVIUJIUTXIRH-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C24H19F4N5O2/c1-33-8-7-21(32-33)17-9-15(12-29-14-17)13-30-22-10-16(5-6-20(22)25)23(34)31-18-3-2-4-19(11-18)35-24(26,27)28/h2-12,14,30H,13H2,1H3,(H,31,34) |
| Chemical Name | 4-fluoro-3-[[5-(1-methylpyrazol-3-yl)pyridin-3-yl]methylamino]-N-[3-(trifluoromethoxy)phenyl]benzamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | The HEK293-DDR1b cells treated with VU6015929 (Compound 7e; 4-100 nM; 24 hours) showed a dose-dependent inhibition of collagen I-induced DDR1 phosphorylation. According to a study of the phosphorylated DDR1/total DDR1 ratio, VU6015929's IC50 is 0.7078 nM [1]. |
| ln Vivo | VU6015929 (Compound 7e) was further examined in a rat IV (0.5 mg/kg)/PO (3 mg/kg) PK trial in 10% EtOH/40% PEG400/50% saline vehicle. VU6015929 demonstrates good in vitro:in vivo correlation (IVIC), has moderate in vivo clearance (CLp = 34.2 mL/min/kg), a half-life of approximately 3 hours, and a moderate volume of distribution at steady state (Vss = 4.3 L) /kg) and 12.5% oral bioavailability with a quick Tmax (0.75 hours) [1]. |
| Cell Assay |
Western Blot Analysis[1] Cell Types: HEK293-DDR1b Cell Tested Concentrations: 4 nM, 20 nM, 100 nM Incubation Duration: 24 hrs (hours) Experimental Results: Inhibits collagen I-induced DDR1 phosphorylation in a dose-dependent manner. Dramatically inhibits the production of type IV collagen. |
| References |
[1]. Discovery of VU6015929: A Selective Discoidin Domain Receptor 1/2 (DDR1/2) Inhibitor to Explore the Role of DDR1 in Antifibrotic Therapy. ACS Med. Chem. Lett. 2019. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~250 mg/mL (~515.01 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (4.28 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (4.28 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0600 mL | 10.3001 mL | 20.6003 mL | |
| 5 mM | 0.4120 mL | 2.0600 mL | 4.1201 mL | |
| 10 mM | 0.2060 mL | 1.0300 mL | 2.0600 mL |